Patel Rajesh R, Subramaniam Rathan M, Mandrekar Jaywant N, Hammack Julie E, Lowe Val J, Jett James R
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Mayo Clin Proc. 2008 Aug;83(8):917-22. doi: 10.4065/83.8.917.
To determine the value of positron emission tomography (PET) in diagnosing occult malignancies in patients with paraneoplastic neurologic syndromes (PNSs) at Mayo Clinic's site in Rochester, MN.
We retrospectively reviewed the medical charts of all 107 patients who underwent PET from January 1, 2000, to July 31, 2006, for the indication of suspected PNS. Three patients did not meet inclusion criteria. PET results were considered positive if increased fludeoxyglucose F 18 uptake indicated malignancy (24 patients). Results from computed tomography were interpreted as positive if any suspect lesion was consistent with malignancy (26 patients).
One hundred four patients with PNS were identified from the PET central database; 73 patients had at least 1 positive result for paraneoplastic antibody, and 31 had antibody-negative PNS. Malignancy was confirmed pathologically in 10 patients, of whom 8 had positive PET results. There were 2 cases of confirmed malignancy (fallopian tube adenocarcinoma and spindle cell uterine carcinoma) for which PET results were negative. Two patients with positive PET results declined biopsy. Computed tomography was able to identify 3 of the 10 malignancies detected. Five cases of malignancy were detected only by PET. All patients with confirmed malignancy had positive results for at least 1 paraneoplastic antibody. One patient with positive results for PNS antibody and negative PET results was diagnosed as having small cell carcinoma on a follow-up PET scan after 27 months. PET had sensitivity, specificity, positive predictive value, and negative predictive value of 80%, 67%, 53%, and 88%, respectively.
PET scan was shown to be more sensitive than computed tomography for detecting occult malignancy (confirmed by positive test results for autoantibody) among patients with suspected PNS. The greatest clinical utility of PET could be in its high negative predictive value.
确定正电子发射断层扫描(PET)在明尼苏达州罗切斯特市梅奥诊所诊断副肿瘤性神经综合征(PNS)患者隐匿性恶性肿瘤中的价值。
我们回顾性分析了2000年1月1日至2006年7月31日期间因疑似PNS接受PET检查的所有107例患者的病历。3例患者不符合纳入标准。如果氟脱氧葡萄糖F 18摄取增加提示恶性肿瘤,则PET结果被视为阳性(24例患者)。如果任何可疑病变与恶性肿瘤一致,则计算机断层扫描结果被解释为阳性(26例患者)。
从PET中央数据库中识别出104例PNS患者;73例患者副肿瘤抗体检测至少有1次阳性结果,31例患者为抗体阴性的PNS。10例患者经病理证实为恶性肿瘤,其中8例PET结果为阳性。有2例确诊恶性肿瘤(输卵管腺癌和子宫梭形细胞癌)PET结果为阴性。2例PET结果阳性的患者拒绝活检。计算机断层扫描能够识别出检测到的10例恶性肿瘤中的3例。仅PET检测到5例恶性肿瘤。所有确诊恶性肿瘤的患者至少有1种副肿瘤抗体检测结果为阳性。1例PNS抗体检测结果阳性且PET结果阴性的患者在27个月后的随访PET扫描中被诊断为小细胞癌。PET的敏感性、特异性、阳性预测值和阴性预测值分别为80%、67%、53%和88%。
对于疑似PNS的患者,PET扫描在检测隐匿性恶性肿瘤(通过自身抗体检测阳性结果证实)方面比计算机断层扫描更敏感。PET最大的临床效用可能在于其较高的阴性预测值。